DEVELOPMENT AND VALIDATION OF A PHARMACOECONOMIC TOOL FOR THE IMPLEMENTATION OF PHARMACEUTICAL CARE FOR HYPERTENSIVE PATIENTS IN THE PUBLIC HEALTH SYSTEM OF BRAZIL

• Grant number: 16/03584-1
• Support Opportunities: Scholarships in Brazil - Doctorate
• Start date: July 01, 2016
• End date: April 11, 2019
• Field of knowledge: Health Sciences - Pharmacy
• Principal Investigator: Leonardo Régis Leira Pereira
• Grantee: Maurilio de Souza Cazarim
• Host Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
• Associated scholarship(s): 17/21240-0 - Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the public health system, BE.EP.DR

Abstract

Systemic arterial hypertension (SAH) is a risk factor for 9.4 million deaths worldwide. In Brazil, HAS assigned an annual cost of about 1.5 billion to the Public Health System (PHS). The Pharmaceutical Care (PC) is able to avoid complications of hypertension and reduce health costs. The PC economic analysis in long-term showed that the net return on investment in this pharmaceutical practice can reach R$ 3,791,111.13 in ten years. One pharmacoeconomic tool for the implementation of the PC in the PHS was created in accordance with the methodology developed for this analysis. However, for this tool become applicable in society is necessary its development and validation. In addition, it is possible to improve it by adding the measurement of monetary return when evaluating morbidities associated complications of hypertension. This study aims to develop and validate the pharmacoeconomic tool to aid in the implementation of the PC in the PHS incorporating Human Disease Netwok to predict the epidemiological impact and return on investment of this pharmaceutical practice. This is a pharmacoeconomic study with application of modeling, nested in a systematic review. The data of the systematic review will be tabulated and applied in the restructuring and development of pharmacoeconomic tool. Additionally, it will be structured a Markov model to project the incidence of diseases associated with complications of hypertension by proteomic studies that resorts the Human Netwok Disease. Thus, this tool will be enhanced for its validation and applicability. It is hoped that the validation of this tool to encourage the implementation of the PC in the PHS and thus improve blood pressure control rate among hypertensive patients, quality of life, reduce morbidities and deaths associated with SAH, reduce spending with indirect costs to health, as well as assisting in the planning and optimization of health resources. There is also the pretension to foster a possible subarea in pharmacoeconomics with the use of proteomics.

Scientific publications

(4)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

JOÃO PAULO VILELA RODRIGUES; MAURÍLIO DE SOUZA CAZARIM; SILVANA GAMA FLORENCIO CHACHÁ; ANA DE LOURDES CANDOLO MARTINELLI; LEONARDO RÉGIS LEIRA PEREIRA. Análise de custo-efetividade é uma estratégia essencial para os sistemas de saúde: as evidências de um estudo sobre terapias para hepatite C. Cadernos de Saúde Pública, v. 36, n. 2, 2020-01-31. (17/21240-0, 16/03584-1)

CRUZ-CAZARIM, ESTAEL L. C.; CAZARIM, MAURILIO S.; OGUNJIMI, ABAYOMI T.; PETRILLI, RAQUEL; ROCHA, EDUARDO M.; LOPEZ, V, RENATA F.. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v. 140, p. 1-10, JUL 2019. (16/03584-1, 14/22451-7)

MAURILIO DE SOUZA CAZARIM; JOÃO PAULO VILELA RODRIGUES; PRISCILA SANTOS CALCINI; THOMAS R. EINARSON; LEONARDO RÉGIS LEIRA PEREIRA. Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital. Revista de Saúde Pública, v. 54, 2020-09-30. (17/21240-0, 16/03584-1)

CAZARIM, MAURILIO DE SOUZA; DOS REIS, TIAGO MARQUES; COELHO DA CRUZ-CAZARIM, ESTAEL LUZIA; LEIRA PEREIRA, LEONARDO REGIS. Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care. Brazilian Journal of Pharmaceutical Sciences, v. 56, 2020. (17/21240-0, 16/03584-1)

Academic Publications

(References retrieved automatically from State of São Paulo Research Institutions)

CAZARIM, Maurilio de Souza. Development and validation of a pharmacoeconomic tool for decision-making in the implementation of pharmaceutical care for hypertensive patients in the public health system. 2019. Doctoral Thesis - Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (PCARP/BC) Ribeirão Preto.